Treatment of Eustachian Tube Dysfunction (ETD) and Facial Pain With Combined Acoustic Vibration and Oscillating Expiratory Pressure

  • STATUS
    Recruiting
  • End date
    Jul 1, 2025
  • participants needed
    70
  • sponsor
    Medical University of South Carolina
Updated on 4 October 2022
a compound
upper respiratory infection
Accepts healthy volunteers

Summary

This study aims to test the safety, efficacy and potential mechanism of action of the SinuSonic device on adults with eustachian tube dysfunction (ETD) or facial pain/pressure. SinuSonic is a medical device that utilizes sound and pressure combined with normal breathing. The study will have 3 aims. Aim 1 will examine healthy controls with no signs of upper respiratory infection, inflammation, or ETD to determine if exhaled nasal Nitric Oxide is increased. Nitric Oxide is a compound in the body that acts as a blood vessel relaxant. Acoustic energy (humming) has been shown to increase nasal Nitric Oxide dramatically, thus equalization of gas pressures between the middle ear, the paranasal sinuses and the nasal cavity may very well explain any efficacy noted. Aim 2 will be performed to examine therapeutic efficacy for ETD. Aim 3 will be performed to examine therapeutic efficacy for sinus pain/pressure.

Details
Condition Eustachian Tube Dysfunction, Facial Pain
Treatment SinuSonic Device
Clinical Study IdentifierNCT04404036
SponsorMedical University of South Carolina
Last Modified on4 October 2022

Eligibility

Yes No Not Sure

Inclusion Criteria

Adults 18 years or older with no symptoms of URI, ETD or other ENT conditions

Exclusion Criteria

Sinonasal or ear surgery within last 3 months (including balloon ET dilation)
Any ENT condition that may impact upper airway to include sinusitis, otitis, or allergies
Upper respiratory illness within last 2 weeks
Topical decongestant use in last week
Current nasal crusting or ulceration on rhinoscopy
History of severe nose bleeding within last 3 months
Known pregnancy
Allergic sensitivity to silicone or any other component of device
Inability to read and understand English
Inability to perform treatment due to underlying medical condition
AIM 2
Inclusion
Adults 18 years or older with diagnosis of ETD by an otolaryngologist
≥6 months of symptoms duration
≥3 ETD symptoms (ear pressure, feeling that ears are clogged, cracking/popping of ears, muffled hearing, tinnitus)
ETDQ-7 score ≥ 3
Audiogram within the last year
Exclusion
Sinonasal or ear surgery within last 3 months (including balloon ET dilation)
Indwelling ear tubes
Tympanic membrane perforation
Hx of cholesteatoma, mastoidectomy, tympanoplasty, or ossicular chain reconstruction
Patulous ET
Hx of Meniere's disease
Moderate or severe nasal valve collapse
Grade 3-4 polyps
Upper respiratory illness within last 2 weeks
Topical decongestant use in last week
Current nasal crusting or ulceration on rhinoscopy
History of severe nose bleeding within last 3 months
Known pregnancy
Allergic sensitivity to silicone or any other component of device
Inability to read and understand English
Inability to perform treatment due to underlying medical condition
AIM 3
Inclusion
Adults 18 years or older who complain of facial pain or pressure
≥3 months of symptoms duration (can be intermittent)
Pain/pressure VAS score ≥ 5
Exclusion
Sinonasal surgery within the last 3 months
Grade 3-4 polyps
Upper respiratory illness within last 2 weeks
Topical decongestant use in last week
Current nasal crusting or ulceration on rhinoscopy
History of severe nose bleeding within last 3 months
Known pregnancy
Allergic sensitivity to silicone or any other component of device
Inability to read and understand English
Inability to perform treatment due to underlying medical condition
Clear my responses

How to participate?

Step 1 Connect with a study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer  to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact

site

Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider

Loading...

Browse trials for

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 

 • 

Private

Reply by • Private
Loading...

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.
Loading...

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note